Multiple Sclerosis (MS): Clinical Trials

1 trial for Multiple Sclerosis (MS), newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 terminated. 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 31Terminated 1

Follow Multiple Sclerosis (MS): new trials by email Literature Review of Multiple Sclerosis (MS) trials Research Report on Multiple Sclerosis (MS)

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Safety and Effectiveness of Nabiximols Oromucosal Spray as Add-on Therapy in Participants With Spasticity Due to Multiple Sclerosis
Nabiximols, Placebo - Multiple Sclerosis (MS)
Phase 3TerminatedJazz Pharmaceuticals1392020-10-012024-05-08

Narrower conditions

Multiple Sclerosis (1)  ·  Muscle Spasticity (1)

Broader conditions

Autoimmune Diseases (1)  ·  Autoimmune Diseases of the Nervous System (1)  ·  Demyelinating Autoimmune Diseases, CNS (1)  ·  Demyelinating Diseases (1)  ·  Immune System Diseases (1)  ·  Muscle Hypertonia (1)  ·  Muscular Diseases (1)  ·  Musculoskeletal Diseases (1)  ·  Nervous System Diseases (1)  ·  Neurologic Manifestations (1)  ·  Neuromuscular Manifestations (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Signs and Symptoms (1)

Interventions

nabiximols (1)

Sponsors

Jazz Pharmaceuticals (1)

Countries

Czechia (1)  ·  Poland (1)  ·  Romania (1)  ·  United Kingdom (1)  ·  United States (1)

NIH funding

2019 (1)